Browsing by Author "Samochowiec, Jerzy"

Now showing 1 - 3 of 3
  • No Thumbnail Available
    Item
    Assessment and Treatment of Negative Symptoms in Schizophrenia-A Regional Perspective
    (2022-02-04) Bitter, Istvan; Mohr, Pavel; Raspopova, Natalia; Szulc, Agata; Samochowiec, Jerzy; Micluia, Ioana Valentina; Skugarevsky, Oleg; Herold, Róbert; Mihaljevic-Peles, Alma; Okribelashvili, Nino; Dragašek, Jozef; Adomaitiene, Virginija; Rancans, Elmars; Chihai, Jana; Maruta, Natalia; Marić, Nadja P; Milanova, Vihra; Tavčar, Rok; Mosolov, Sergey; Department of Psychiatry and Narcology
    Clinicians and researchers consider that there are a variety of symptoms that constitute negative symptoms in schizophrenia, and they may use different definitions for the same symptoms. These differences are also reflected in a variety of negative symptom rating scales. Both research and clinical work are negatively affected by the lack of consensus regarding the symptoms that constitute negative symptoms in schizophrenia. Leading research groups have investigated ways to reduce heterogeneity in the domain of negative symptoms in schizophrenia; however, little attention has been paid to regional differences in the concepts of negative symptoms in schizophrenia. The objective of this review was to collect and summarize information about the assessment and treatment of negative symptoms of schizophrenia in Central and Eastern Europe (CEE). Nineteen experts from 17 countries in CEE participated in this project. The participants collected information about their countries, including the following: (1) the most important publications about negative symptoms in schizophrenia (irrespective of the time of their publication); (2) the most frequently used negative symptom of schizophrenia in clinical practice; (3) definitions of frequently used negative symptoms; and (4) treatment of negative symptoms in schizophrenia. The participating experts/countries most frequently reported the following five negative symptoms: avolition, blunted affect, alogia, asociality, and anhedonia. Several experts also considered other symptoms as belonging to the negative symptom domain, such as a decrease in energy level and changes in personality. The importance of evaluating the long-term course and the relationship between negative symptoms and other symptom domains was also noted. No noticeable differences were reported in the treatment of negative symptoms compared to currently published guidelines and algorithms. The most frequently reported negative symptoms included those defined by the NIMH-MATRICS consensus statement on negative symptoms and recently endorsed in a guidance paper of the European Psychiatric Association. The main differences in the concepts, names, and definitions of primary negative symptoms, especially those related to personality changes, and to the evaluation of the long-term course and relationship between different symptom domains in CEE compared to the current English language literature deserve the attention of psychiatrists and other professionals in this field.
  • No Thumbnail Available
    Item
    Clinical decision-making style preferences of European psychiatrists : Results from the Ambassadors survey in 38 countries
    (2022-10-21) Rojnic Kuzman, Martina; Slade, Mike; Puschner, Bernd; Scanferla, Elisabetta; Bajic, Zarko; Courtet, Philippe; Samochowiec, Jerzy; Arango, Celso; Vahip, Simavi; Taube, Maris; Falkai, Peter; Dom, Geert; Izakova, Lubomira; Carpiniello, Bernardo; Bellani, Marcella; Fiorillo, Andrea; Skugarevsky, Oleg; Mihaljevic-Peles, Alma; Telles-Correia, Diogo; Novais, Filipa; Mohr, Pavel; Wancata, Johannes; Hultén, Martin; Chkonia, Eka; Balazs, Judit; Beezhold, Julian; Lien, Lars; Mihajlovic, Goran; Delic, Mirjana; Stoppe, Gabriela; Racetovic, Goran; Babic, Dragan; Mazaliauskiene, Ramune; Cozman, Doina; Hjerrild, Simon; Chihai, Jana; Flannery, William; Melartin, Tarja; Maruta, Nataliya; Soghoyan, Armen; Gorwood, Philip; Department of Psychiatry and Narcology
    Background While shared clinical decision-making (SDM) is the preferred approach to decision-making in mental health care, its implementation in everyday clinical practice is still insufficient. The European Psychiatric Association undertook a study aiming to gather data on the clinical decision-making style preferences of psychiatrists working in Europe.Methods We conducted a cross-sectional online survey involving a sample of 751 psychiatrists and psychiatry specialist trainees from 38 European countries in 2021, using the Clinical Decision-Making Style - Staff questionnaire and a set of questions regarding clinicians' expertise, training, and practice.Results SDM was the preferred decision-making style across all European regions ([central and eastern Europe, CEE], northern and western Europe [NWE], and southern Europe [SE]), with an average of 73% of clinical decisions being rated as SDM. However, we found significant differences in non-SDM decision-making styles: participants working in NWE countries more often prefer shared and active decision-making styles rather than passive styles when compared to other European regions, especially to the CEE. Additionally, psychiatry specialist trainees (compared to psychiatrists), those working mainly with outpatients (compared to those working mainly with inpatients) and those working in community mental health services/public services (compared to mixed and private settings) have a significantly lower preference for passive decision-making style.Conclusions The preferences for SDM styles among European psychiatrists are generally similar. However, the identified differences in the preferences for non-SDM styles across the regions call for more dialogue and educational efforts to harmonize practice across Europe.
  • No Thumbnail Available
    Item
    Clinician treatment choices for post-traumatic stress disorder : ambassadors survey of psychiatrists in 39 European countries
    (2024-03-07) Rojnic Kuzman, Martina; Padberg, Frank; Amann, Benedikt L; Schouler-Ocak, Meryam; Bajic, Zarko; Melartin, Tarja; James, Adrian; Beezhold, Julian; Artigue Gómez, Jordi; Arango, Celso; Jendricko, Tihana; Ismayilov, Jamila; Flannery, William; Chumakov, Egor; Başar, Koray; Vahip, Simavi; Dudek, Dominika; Samochowiec, Jerzy; Mihajlovic, Goran; Rota, Fulvia; Stoppe, Gabriela; Dom, Geert; Catthoor, Kirsten; Chkonia, Eka; Heitor Dos Santos, Maria João; Telles, Diogo; Falkai, Peter; Courtet, Philippe; Patarák, Michal; Izakova, Lubomira; Skugarevski, Oleg; Barjaktarov, Stojan; Babic, Dragan; Racetovic, Goran; Fiorillo, Andrea; Carpiniello, Bernardo; Taube, Māris; Melamed, Yuval; Chihai, Jana; Cozman, Doina Constanta Maria; Mohr, Pavel; Szekeres, György; Delic, Mirjana; Mazaliauskienė, Ramunė; Tomcuk, Aleksandar; Maruta, Nataliya; Gorwood, Philip; Department of Psychiatry and Narcology
    BACKGROUND: Considering the recently growing number of potentially traumatic events in Europe, the European Psychiatric Association undertook a study to investigate clinicians' treatment choices for post-traumatic stress disorder (PTSD). METHODS: The case-based analysis included 611 participants, who correctly classified the vignette as a case of PTSD, from Central/ Eastern Europe (CEE) (n = 279), Southern Europe (SE) (n = 92), Northern Europe (NE) (n = 92), and Western Europe (WE) (N = 148). RESULTS: About 82% woulduse antidepressants (sertraline being the most preferred one). Benzodiazepines and antipsychotics were significantly more frequently recommended by participants from CEE (33 and 4%, respectively), compared to participants from NE (11 and 0%) and SE (9% and 3%). About 52% of clinicians recommended trauma-focused cognitive behavior therapy and 35% psychoeducation, irrespective of their origin. In the latent class analysis, we identified four distinct "profiles" of clinicians. In Class 1 (N = 367), psychiatrists would less often recommend any antidepressants. In Class 2 (N = 51), clinicians would recommend trazodone and prolonged exposure therapy. In Class 3 (N = 65), they propose mirtazapine and eye movement desensitization reprocessing therapy. In Class 4 (N = 128), clinicians propose different types of medications and cognitive processing therapy. About 50.1% of participants in each region stated they do not adhere to recognized treatment guidelines. CONCLUSIONS: Clinicians' decisions for PTSD are broadly similar among European psychiatrists, but regional differences suggest the need for more dialogue and education to harmonize practice across Europe and promote the use of guidelines.